STUDY OF 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) IN PATIENTS WITH DISSEMINATED MELANOMA

被引:0
作者
GERNER, RE
MOORE, GE
机构
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT SURG,BUFFALO,NY 14203
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,PUBL HLTH RES GRP,BUFFALO,NY 14203
来源
CANCER CHEMOTHERAPY REPORTS PART 1 | 1973年 / 57卷 / 01期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:83 / 84
页数:2
相关论文
共 5 条
[1]   CLINICAL EVALUATION OF 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE IN MALIGNANT MELANOMA AND OTHER NEOPLASMS - COMPARISON OF TWICE-WEEKLY AND DAILY ADMINISTRATION SCHEDULES [J].
GOTTLIEB, JA ;
SERPICK, AA .
ONCOLOGY, 1971, 25 (03) :225-&
[2]   IMPROVED SYSTEMIC CHEMOTHERAPY FOR MALIGNANT MELANOMA [J].
LARSEN, RR ;
HILL, GJ .
AMERICAN JOURNAL OF SURGERY, 1971, 122 (01) :36-&
[3]  
LUCE JK, 1970, CANCER CHEMOTH REP 1, V54, P119
[4]  
NATHANSON L, 1971, CLIN PHARMACOL THER, V12, P955
[5]  
SKIBBA JL, 1969, CANCER RES, V29, P1944